Investegate |Sanofi - Aventis Groupe Announcements | Sanofi - Aventis Groupe: Press Release: Sanofi continues on path to industry leadership in Immunology with Dupixent® (dupilumab) as key driver
Investegate announcements from Sanofi - Aventis Groupe, Press Release: Sanofi continues on path to industry leadership in Immunology with Dupixent® (dupilumab) as key driver